Oxford Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,249
Closed -$194K 569
2025
Q1
$194K Buy
+14,249
New +$194K 0.09% 350
2019
Q2
Sell
-16,384
Closed -$380K 1758
2019
Q1
$380K Buy
+16,384
New +$380K 0.01% 1334
2018
Q1
Sell
-122,995
Closed -$1.85M 1672
2017
Q4
$1.85M Buy
+122,995
New +$1.85M 0.04% 618